The cavernous hemangioma is a rare benign vascular tumor. About 50 cases of this disease were found in the literature over the last century and only 9 cases of cavernous hemangioma on the pregnant uterus were published it comes into cavernous or capillary form. The symptomatology is not unequivocal and when it occurs during pregnancy or postpartum, it causes life-threatening cataclysmic hemorrhage. Antenatal diagnosis is difficult and requires a multidisciplinary approach with pathologists, radiologists and gynecologists to avoid these complications or unnecessary hysterectomies. The diagnosis is histological. Hysterectomy is possible after failure of conservative treatment means. We report a rare case, a novel mixed cavernous hemangioma of the body associated with a capillary hemangioma of the cervix in a patient of 28 years 5th visors with recurrent genital bleeding in the postpartum period leading to a hysterectomy.

No abstract

No abstract

ObjectiveTo generate data on the nature and duration of cervical cancer symptoms, risk factors for delayed consultation, and diagnosis of adolescent and young adult groups in Côte d'Ivoire.MethodsThis is a hospital-based cross-sectional study, conducted from July 2012 to May 2018, at the Department of Gynecology of the Yopougon teaching hospital in Cote d’Ivoire. The inclusion criteria were those who were under 40 years of age at the time of diagnosis with oral and written consent. Those whose information was more than 10% insufficient for the standards were excluded from the study. The survey files standardized anonymous pre-established data collected using medical records followed by phone calls.ResultsThe average age of the participants was 34±4.95 years with a minimum of 21 years. The mean parity per woman was 3.49 ± 3.54. 34.9% were HIV positive. The median patient delay was 122 days with a long delay in 84.62% of patients. The median time to total diagnosis was 209 days with a longer total delay in diagnosis of 87.18%. 41% of patients honored their treatment, 68.75% of which had received surgery, and 31.25% of which had received chemotherapy. The 5-year survival rate was 65%.ConclusionThe Ivorian health system must focus on primary and secondary prevention, the only guarantee to decrease the morbidity and mortality indicators linked to cervical cancer.